Forecast & RatingOnly 1 analyst currently covers Co-Diagnostics (CODX.US), with a price target of $4.00 and a rating of "Overweight". The sample is very small, so treat this as a reference only. Data as of Sep 23, 2026; this does not constitute investment advice.
Sep 23, 2026Price forecast
$4.00273.83%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 28, 2026
Forecast met13.6%
Stock price$1.07
Avg. target$4.0
High target$4
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.